3
3 Comments

Why I stopped relying on pure LLM APIs (and started pre-building my AI's "brain")

Hey makers,

When I first started building my AI assistant, the temptation to just hook up a slick frontend to OpenAI’s API was huge. I call it the "Siren Song of Instant AI." It's so easy to build a wrapper, prompt it, and launch.

But for my specific use case (health and clinical intelligence), I quickly hit two walls:

Latency: Waiting 5+ seconds for an LLM to "think" and stream a response kills the user experience.

Hallucinations: In my niche, I cannot afford the AI making up facts or citing non-existent clinical studies.

So, I made a hard architectural pivot. Instead of relying on on-the-fly generation or standard RAG, I decided to take the long, painful route: Forging a Database of Truth.

Right now, I am manually pre-building our AI's "brain." I'm systematically consolidating, reviewing, and structuring thousands of verified clinical studies and data points into a closed, localized database.

When a user asks a question, the AI doesn't generate an answer from scratch. It acts as a zero-latency router, instantly fetching pre-verified blocks of data.

The Trade-off:
The upfront cost is brutal. It’s taking me way longer to build this manually. I'm sacrificing speed-to-market.
But the ROI is near zero-latency responses and 100% confidence in the output accuracy. No hallucinations.

Curious how other solo founders are handling the latency vs. accuracy trade-off in your AI apps? Are you pre-building your datasets, or relying on advanced RAG on the fly?

(I documented the raw details of this architectural shift in my recent Founder's Log if anyone wants to deep dive: https://kevinsarchive.com/vitabase-2-the-zero-latency-bet-why-im-pre-building-our-ais-brain/)

on August 5, 2026
  1. 1

    I do think agents can be very useful for repetitive tasks, and we already use them that way.

    My bigger concern starts when the agent becomes more like a personal assistant—sending emails, accessing documents, or taking actions on my behalf. To make that work, I eventually have to give it access to sensitive data, credentials, and API keys.

    At that point, the question is no longer just where the agent should stop. It’s how much of my data and authority I’m willing to trust it with in the first place.

  2. 1

    You're framing the manual curation as a brutal cost, but in clinical/health it's your moat, not your tax. Anyone can wrap an LLM in a weekend, that's why wrappers have no defensibility. A hand-verified database of real clinical studies can't be cloned by copying your prompt. The slow painful part is the asset, and it's what makes speed-to-market irrelevant for everyone chasing you.

    Which reframes the trade-off: the curated dataset is your product, the LLM is just the interface to it. Lead with "verified, no hallucinations" as the whole value prop, in a niche where a made-up study is real harm.

    How are you keeping the dataset current as new studies publish?

  3. 1

    The part that caught my attention is the commitment behind the trade-off.

    You’re deliberately accepting a much longer path to market for an architecture you believe needs to exist before users arrive.

    What would make you reconsider that bet?